HK1021329A1 - Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation. - Google Patents

Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation.

Info

Publication number
HK1021329A1
HK1021329A1 HK00100293A HK00100293A HK1021329A1 HK 1021329 A1 HK1021329 A1 HK 1021329A1 HK 00100293 A HK00100293 A HK 00100293A HK 00100293 A HK00100293 A HK 00100293A HK 1021329 A1 HK1021329 A1 HK 1021329A1
Authority
HK
Hong Kong
Prior art keywords
percutaneous
azelastine hydrochloride
skin irritation
preparation
absorbability
Prior art date
Application number
HK00100293A
Other languages
English (en)
Inventor
Noriko Mizobuchi
Sayuri Seto
Original Assignee
Teikoku Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Seiyaku Kk filed Critical Teikoku Seiyaku Kk
Publication of HK1021329A1 publication Critical patent/HK1021329A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK00100293A 1997-07-02 2000-01-18 Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation. HK1021329A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17724297A JP4138910B2 (ja) 1997-07-02 1997-07-02 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤
PCT/JP1998/002953 WO1999001137A1 (fr) 1997-07-02 1998-06-29 Preparation percutanee contenant de l'hydrochlorure d'azelastine, presentant une bonne absorbabilite percutanee et une action d'irritation de la peau reduite

Publications (1)

Publication Number Publication Date
HK1021329A1 true HK1021329A1 (en) 2000-06-09

Family

ID=16027646

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00100293A HK1021329A1 (en) 1997-07-02 2000-01-18 Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation.

Country Status (11)

Country Link
US (1) US6299888B1 (xx)
EP (1) EP0958823B1 (xx)
JP (1) JP4138910B2 (xx)
KR (1) KR20000068285A (xx)
AT (1) ATE286732T1 (xx)
AU (1) AU746831B2 (xx)
CA (1) CA2264693C (xx)
DE (1) DE69828586T2 (xx)
ES (1) ES2234123T3 (xx)
HK (1) HK1021329A1 (xx)
WO (1) WO1999001137A1 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4138910B2 (ja) * 1997-07-02 2008-08-27 帝國製薬株式会社 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤
US7029694B2 (en) * 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
JP4387639B2 (ja) * 2002-07-16 2009-12-16 久光製薬株式会社 経皮吸収製剤
JP4468669B2 (ja) * 2003-09-22 2010-05-26 久光製薬株式会社 低刺激性貼付剤
EP2564873A4 (en) * 2010-04-28 2013-11-06 Hisamitsu Pharmaceutical Co MEANS FOR THE SUPPRESSION OF SKIN IRRITATIONS AND TRANSDERMAL PREPARATION THEREOF
ES2547888T3 (es) * 2010-04-28 2015-10-09 Hisamitsu Pharmaceutical Co., Inc. Preparación que contiene donepezilo absorbible por vía transdérmica
RU2543326C2 (ru) * 2012-08-21 2015-02-27 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения зуда кожи
EA201791321A1 (ru) * 2012-12-19 2018-04-30 Саркоуд Байосайенс Инк. Составы ингибитора lfa-1
US9987361B1 (en) 2014-12-29 2018-06-05 Noven Pharmaceuticals, Inc. Compositions and method for sustained drug delivery by active transdermal technology

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE84968T1 (de) * 1987-11-13 1993-02-15 Asta Medica Ag Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge.
MC2025A1 (fr) 1988-04-20 1990-04-25 Asta Pharma Ag Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
JP2794021B2 (ja) * 1988-11-02 1998-09-03 エーザイ株式会社 アゼラスチン或いはその塩類含有経皮適用製剤
US5110814A (en) * 1989-01-11 1992-05-05 Asta Pharma Ag Azelastine and its salts used to combat psoriasis
ATE107643T1 (de) * 1989-05-05 1994-07-15 Asta Medica Ag Salze des azelastins mit verbesserter löslichkeit.
JP2849937B2 (ja) * 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
JP3190441B2 (ja) * 1992-07-20 2001-07-23 エーザイ株式会社 塩酸アゼラスチンを含有する安定な製剤
JP4138910B2 (ja) * 1997-07-02 2008-08-27 帝國製薬株式会社 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤

Also Published As

Publication number Publication date
WO1999001137A1 (fr) 1999-01-14
AU7936098A (en) 1999-01-25
DE69828586D1 (de) 2005-02-17
JPH1121240A (ja) 1999-01-26
US6299888B1 (en) 2001-10-09
EP0958823B1 (en) 2005-01-12
CA2264693A1 (en) 1999-01-14
ES2234123T3 (es) 2005-06-16
EP0958823A4 (xx) 1999-11-24
KR20000068285A (ko) 2000-11-25
EP0958823A1 (en) 1999-11-24
CA2264693C (en) 2007-08-28
AU746831B2 (en) 2002-05-02
JP4138910B2 (ja) 2008-08-27
DE69828586T2 (de) 2006-01-19
ATE286732T1 (de) 2005-01-15

Similar Documents

Publication Publication Date Title
HK1035194A1 (en) Novel pyridazine derivatives and drugs containing the same as the active ingredient
HK1018218A1 (en) Tranilast-containing preparation for external application and method of producing the same
EP0768079A4 (en) HAIR GROWTH STIMULATING PRODUCT
HUP0201637A3 (en) Novel preparation and administration form comprising an acid-labile active compound
HUP0900587A3 (en) Stable salts of 3,3-diphenylpropylamines and preparation thereof
EP0990648A4 (en) DERIVATIVES OF 4-CHINOLOL AND AGRICULTURAL AND GARDENING BACTERICIDES THAT CONTAIN THEM AS AN ACTIVE COMPONENT
ZA9880B (en) Table for the controlled release of active agents
HK1021329A1 (en) Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation.
ZA988718B (en) Drug formulation having controlled release of active compound
TW264386B (xx)
EG20417A (en) Dihalopropene compounds insecticide acaricide containing same as active ingredient
HUP0101490A3 (en) Therapeutic anti-cold agent containing isomalt as an active ingredient
WO1998010762A3 (en) Controlled release dosage form of r-(z)-alpha-methoxyimino-alpha-(1-azabicyclo2.2oct-c-yl)acetonitrile monohydrochloride
HK1035993A1 (en) Aqeous agents for combating parasitic insects and acarina in human beings
EP0965342A4 (en) PREPARATION FOR PERCUTANEOUS ADMINISTRATION
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
HUP0104238A3 (en) Benzoxazole derivatives and drugs containing the same as the active ingredient and their use
AU5577698A (en) Chromone derivatives and bactericidal and herbicidal agent containing the same as the active ingredient
AU2002322424A8 (en) Novel methods and formulations for administration of active agents
ATE236613T1 (de) Hautdepigmentierungsmittel
EP0246573A3 (en) Pharmaceutical composition containing a 8-chlorobenzothiazepine compound and its use
HUP9801264A3 (en) 3,5-difluoropyridine derivatives, their preparation and use, and herbicidal compositions containing them as active ingredient
EP0987244A4 (en) IODOPROPARGYL DERIVATIVES AND ANTIMICROBIAL AGENTS CONTAINING THEM AS ACTIVE INGREDIENT
EP0417632A3 (en) 2-ethoxymethyl-5-hydroxy-gamma-pyrone and melanogenesis-inhibiting endermic preparation containing the same compound as active ingredient
CA2244679A1 (en) Tranilast-containing preparation for external application and method of producing the same

Legal Events

Date Code Title Description
AM Amended specification (according sect 146 of patent law)

Free format text: ADDITION OF INTERNATIONAL APPLICATION?S DETAILS:

Effective date: 20050523

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120629